Form 4: Medtronic CAO Acquires Shares via RSU Vesting, Options

Medtronic's Chief Accounting Officer, Denise L. Blomquist, reported the acquisition of ordinary shares through RSU settlements and stock option exercises, alongside tax-related dispositions.

Summary

• Denise L. Blomquist, Medtronic plc's Chief Accounting Officer, reported multiple transactions involving Medtronic ordinary shares on August 1, 2025.
• Acquired 246 ordinary shares from the settlement of performance-vesting restricted stock units (RSUs) granted on August 1, 2022, including earned dividend equivalents.
• Acquired 58 ordinary shares from the settlement of performance-vesting RSUs granted on October 31, 2022, including earned dividend equivalents.
• Acquired 214 ordinary shares through the exercise of stock options at a price of $78 per share.
• Disposed of a total of 515 ordinary shares (93, 22, 204, and 196 shares) at a price of $89.34 per share to cover tax obligations related to the vesting and settlement of restricted stock units.
• Following these transactions, the direct beneficial ownership of ordinary shares by Ms. Blomquist was 12,428.

Sentiment

Score: 7

Explanation: The transactions reflect the vesting of performance-based equity awards and the exercise of stock options, indicating the achievement of performance targets and a standard part of executive compensation. While there are dispositions for tax purposes, the underlying acquisitions represent a positive outcome for the executive and suggest continued alignment with shareholder interests.

Positives

• Acquisition of 246 ordinary shares from performance-vesting restricted stock units, indicating successful achievement of performance targets.
• Acquisition of 58 ordinary shares from performance-vesting restricted stock units, further indicating successful achievement of performance targets.
• Exercise of stock options resulting in the acquisition of 214 ordinary shares, suggesting confidence in the company's future performance.

Negatives

• Disposition of 515 ordinary shares to cover tax obligations, which is a common practice but reduces direct shareholding.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The reported transactions are related party transactions as they involve an executive officer of Medtronic plc acquiring and disposing of company shares.

Stakeholder Impact

• Shareholders: The vesting of performance-based awards aligns executive incentives with shareholder value creation. The exercise of options and subsequent tax-related sales are routine and generally not indicative of a change in company fundamentals.
• Employees: The report highlights the structure of executive compensation, which can influence broader employee compensation strategies.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of performance-based restricted stock units and the exercise of stock options, followed by tax-related dispositions. Such transactions are expected and do not typically signal a change in the company's fundamental outlook or performance. Therefore, it provides no new information that would warrant a change in investment recommendation.

Keywords

Medtronic, MDT, SEC Form 4, Insider Trading, Stock Options, Restricted Stock Units, RSU, Performance Share Unit, PSU, Share Acquisition, Share Disposition, Tax Withholding, Corporate Officer, Denise Blomquist, Chief Accounting Officer